Huperzine A 200 mcg

Huperzine A 200 mcg

Life Extension4.6 (584 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals

Product analysis

73 out of 100

Huperzine A 200 mcg targets a brain chemical involved in memory. Whether it improves memory or attention in healthy adults remains uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The plant extract source is identified. The quality of its particular form remains uncertain.

Ingredient Transparency100

The huperzine amount and plant source are stated. The single-ingredient label makes the declared content straightforward to compare.

Value For Money100

The serving offers good value for its huperzine content. The simple formula makes clear which ingredient you are paying for.

Customer Satisfaction75

Customer ratings are very positive across a moderate number of reviews. Their feedback does not establish memory benefits in healthy adults.

Product Focus63

The single ingredient keeps the focus on brain signalling related to cognition. Findings in people with cognitive disease cannot establish routine memory or attention benefits in healthy adults.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.36
Customer rating
4.6 · 584 ratings
Report analysis

Goals

Mental Focus
Impact
Lower effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Huperzine · 200 mcg
Study evidence
Huperzine Not classified

No linked studies yet.

Cognitive Support
Impact
Highest effect
A Ingredient FitC PathwaysA EvidenceA+ Formulation Logic
Huperzine · 200 mcg

Huperzine inhibits the enzyme that breaks down acetylcholine, a chemical involved in nerve signalling. Its saved contribution is substantial within that signalling category, but the supplied cognitive trial concerns people with Alzheimer's disease. The 200 mcg serving therefore cannot be taken as an established dose for improving memory or attention in healthy adults.

How this product is rated for Cognitive Support

Ingredient fit95

Huperzine is the sole credited ingredient and reaches the saved full amount anchor.
Goal fit
Huperzine gives the product a focused cognitive purpose, with additional links to other goals.
Dose adequacy
The 200 mcg serving receives full saved amount credit; disease-cohort dosing does not establish a healthy-adult cognitive dose.

Pathways60

The saved contribution concentrates on acetylcholine signalling.
Depth
Acetylcholine signalling reaches full coverage in the saved result.
Breadth
Acetylcholine signalling is the only pathway meeting the saved coverage threshold.

Evidence91

Huperzine supplies the saved evidence contribution, but the cited treatment population limits its relevance to healthy adults.
Evidence strength
The saved evidence finding is led by huperzine; enzyme inhibition alone does not demonstrate cognitive improvement.
Studied preparation
The saved result gives huperzine full preparation credit.

Formulation logic100

Huperzine needs no partner for its saved contribution, and no configured conflict was found.
Partner coverage
The saved huperzine contribution does not require another ingredient.
Conflicts
None of the configured ingredient conflicts was matched.
Effective doses
Huperzine passes the saved minimum amount threshold.
Study evidence
Huperzine Supportive 22 studies
Brain Health
Impact
Highest effect
A Ingredient FitD+ PathwaysA EvidenceA+ Formulation Logic
Huperzine · 200 mcg

Huperzine affects the breakdown of acetylcholine, a signalling chemical involved in cognition. This mechanism explains its placement in the saved comparison, but does not establish improvement in healthy adults. Disease-treatment findings do not establish routine memory maintenance, acute enhancement or a particular cycling schedule from this label.

How this product is rated for Brain Health

Ingredient fit95

The declared ingredients and serving amounts support this comparison, with benefit expectations limited by their specific roles and preparations.
Goal fit
The ingredients counted here are concentrated on brain-related roles, although wider product uses also affect the saved comparison.
Dose adequacy
Declared serving amounts provide the amount comparison; meeting these reference amounts does not establish a proven cognitive effect.

Pathways54

The represented areas describe biological roles. Their presence does not by itself demonstrate improved cognition.
Depth
The strongest represented area is acetylcholine signalling, describing ingredient roles rather than a demonstrated outcome.
Breadth
The saved coverage extends to acetylcholine signalling, without proving broad cognitive improvement.

Evidence90

The saved evidence findings must be read alongside the limits of the supplied studies and preparation details.
Evidence strength
Huperzine leads the saved evidence comparison, but the supplied population and outcome limitations still apply.
Studied preparation
The saved comparison treats the counted preparations as matched; this does not extend findings beyond the studied populations and outcomes.

Formulation logic100

The counted ingredients meet the saved amount and partner checks, with no configured conflict identified.
Partner coverage
No counted ingredient is missing a required partner in the supplied comparison; this does not establish a combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied comparison.
Effective doses
All counted ingredients reach the saved minimum amount threshold; that threshold is not a proven effective cognitive dose.
Study evidence
Huperzine Supportive 17 studies
Productivity Boost
Impact
Lower effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Huperzine · 200 mcg
Study evidence

Ingredients

IngredientAmount per servingScore
Huperzine A (Toothed Clubmoss extract)
200 mcg 79
Adults 18–50
Report overview
C Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  2. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  3. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsBrain Health Cognitive Support forHuperzine
  4. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  5. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  6. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  7. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine
  8. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsProductivity Boost forHuperzine